UGT1A1 and metabolic dysfunction-associated steatotic liver disease: The prevalence of UGT1A1*28 genotypes or compound heterozygous genotypes did not differ significantly between the NAFLD and non-NAFLD groups in the crude analysis and in the fully adjusted model.